Navigation Links
Romark Announces Data Presented at AASLD Meeting 2010
Date:11/1/2010

neau, W. Ray Kim; Mayo Clinic College of Medicine, Rochester, MN. Poster session: Sunday, October 31, 8:00 am – 5:30 pm.

Dr. Kim and his colleagues from the Mayo Clinic have reported results of a pilot study of nitazoxanide in 5 male liver transplant patients who received oral nitazoxanide 1000 mg b.i.d. immediately prior to transplant and for 72 hours thereafter.  Each of the 5 patients experienced a decrease in HCV viral load during the first 72 hours.  Within 4 days after completing therapy, HCV RNA levels were similar to pre-transplant levels.  Nitazoxanide was well tolerated with the primary adverse events being abdominal pain and nausea which resolved.  Post-transplant viral kinetics for these 5 patients were similar to a historical control group of 5 transplant recipients, except that there was a greater log drop in nitazoxanide-treated patients within the first 24 hours.  The authors concluded that this suggests that peri-transplant induction with nitazoxanide, potentially at a higher dose, may serve as a novel adjunct to other antiviral regimens to prevent HCV recurrence.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease that is caused by the hepatitis C virus (HCV). It is the most common cause of chronic hepatitis in the U.S. and may eventually lead to cirrhosis, liver cancer and liver failure. The disease is transmitted by contact with HCV-infected blood.  A large majority of those infected do not show symptoms, but fatigue, abdominal pain and nausea can be common.  The current standard treatment of care, peginterferon and ribavirin, is effective in about half of all patients treated. Treatment outcomes vary based on a number of factors including genotype, viral load, genetic factors, stage of liver disease, co-infections and ability to adhere to treatment.  According to the Centers for Disease Control, approximately 3.2 million Americans are chronically infected wit
'/>"/>

SOURCE Romark Laboratories, L.C.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
2. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
3. NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design
4. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
5. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
6. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
7. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
8. Romark Laboratories Raises $18 Million in Institutional Financing
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
11. Stryker Announces Acquisition of Privately-Held Porex Surgical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty ... disease and overall health is pleased to provide you with ... outlook for 2015 from the CEO, Mr. Eugene Bortoluzzi ... like to take this opportunity to share with you the ...
(Date:1/22/2015)... MINNEAPOLIS , Jan. 22, 2015  Bio-Techne Corporation (NASDAQ: ... launched Ella, the first member of the new Simple ... ProteinSimple brand.  This launch represents the re-branding of the ... The Simple Plex platform is a transformative immunoassay technology ...
(Date:1/22/2015)... 2015 Increasing sophistication among enterprise buyers of language ... in 2015, says Moravia CMO, Renato ... by market research firm Common Sense Advisory, 15 percent ... translation and localization needs. "From a language industry perspective, ...
Breaking Medicine Technology:Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
(Date:1/22/2015)... The federal court overseeing thousands of vaginal mesh ... District of West Virginia has upheld a $2 million verdict ... trial. In an Order dated January 21st, the Court denied ... C.R. Bard had not proven a miscarriage of justice. (Cisson ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... Boulder, Colorado (PRWEB) January 22, 2015 Four years ... is Queen – which coincided with the marriage of Avasa & ... album, THE ROAD, which is scheduled for release through White Swan ... heartfelt message that there is a sacred path available to all ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store ... announces its latest collection of wedding dresses , and ... issue is the wedding dress on your big day; the ... life. Every bride wants to find the most suitable wedding ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... announced an agreement with Schwarz Pharma AG under which it ... drug that can be a treatment option for an overactive ... affects up to 100 million people around the world," said ... Human Health. "We are excited about the potential of this ...
... time researchers have studied deeply about fat cells, called adipocytes ... .Research has now revealed that these Fat cells around coronary ... University of Iowa researchers have revealed that fat cells release ... upon a time, were thought to have a role of ...
... government a confirmed case of mad-cow disease in a cow ... case was of a 6-year-old dairy cow which was identified ... for mad-cow disease. ,In a written statement, "This finding ... which BSE is known to concentrate in infected animals are ...
... wildlife rescue group has raised concerns over swans and other wild ... fear //. Despite pleas from wildlife rescue groups, Canada geese, peregrine ... ,The attempts of Salisbury Wildlife Rescue workers to save a swan ... ended up in vain. The bird had to be eventually destroyed ...
... country focuses on headline-grabbing diseases, hemophilia, a little known blood ... over 50,000 people affected. // ,World Hemophilia ... effort to secure appropriate care and treatment for a disease ... a defect in the genes. ,"The disease might ...
... palmetto, commonly used for treatment of enlarged prostate is nothing ... Francisco VA Medical Center and the Northern California Kaiser Permanente ... published in the New England Journal of Medicine. ... is a very common condition that leads to urinary problems ...
Cached Medicine News:Health News:Fat cells lethally connected to heart disease 2Health News:Saw Palmetto Extract No Good In Improving Prostate Health 2
... introduces new high precision femtosecond laser technology ... opportunity to offer their patients a safer, ... creating the corneal flap. By using ... IntraLASIK software, surgeons may avoid the complications ...
... Teco Diagnostics manufactures fine urine chemistry ... urine chemistry reagent strips from start ... offer more economical prices compared to ... quality. Teco Diagnostics urine reagent strips ...
... Long term complications associated with diabetes ... the health and quality of life of ... costs. These complications are known to be ... The discovery that the level of haemoglobin ...
The Lifestream Plus Cholesterol Monitor provides you with a comprehensive tool to help you monitor your cholesterol as part of your wellness program....
Medicine Products: